BioSpace News Archive

Confo Therapeutics Awarded EUR 1.7M VLAIO Grant to Expand Application of ConfoBody® Drug Discovery and Development Technology in Rare Diseases

Confo Therapeutics announced that it has been awarded a EUR 1.7 million grant from Flanders Innovation & Entrepreneurship.

June 28, 2022
·
3 min read
MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis

MRM Health announced that they have received regulatory approval from the Federal Agency for Medicines and Health Products in Belgium to start a Phase 2 trial with the novel next-generation optimized consortium therapy, MH002, in patients with Pouchitis.

June 28, 2022
·
4 min read
Biotech Bay

French Defense Innovation Agency Investigates the Use of DNA Script’s SYNTAX System to Synthesize Custom qPCR Probes for On-demand Detection of Biothreats

DNA Script, a world leader in Enzymatic DNA Synthesis for DNA on demand, has announced the first successful qPCR assays using primers and probes synthesized by a customer via enzymatic synthesis using the company’s SYNTAX System DNA printer.

June 28, 2022
·
3 min read
Business

Roivant Sciences Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2022 and Provides Business Update

Roivant Sciences Ltd. reported its financial results for the fourth quarter and fiscal year ended March 31, 2022 and provided an update on the Company’s operations.

June 28, 2022
·
22 min read
Drug Development

Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference

Pyxis Oncology, Inc., an oncology company focused on developing next-generation therapeutics for difficult-to-treat cancers, announced that the Company will present at the H.C. Wainwright Preclinical Cancer Drug Discovery - Antibody Drug Conjugates virtual conference.

June 28, 2022
·
1 min read
Biotech Beach

Evofem Reaches Agreement with One of the Largest Pharmacy Benefit Managers in the U.S. for Access to Phexxi®

Evofem Biosciences, Inc., announced it has reached an agreement with one of the nation’s largest pharmacy benefit managers to ensure most women covered by this plan can fill their Phexxi® prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy.

June 28, 2022
·
5 min read
BioCapital

Graybug Announces Review of Strategic Alternatives

Graybug Vision, Inc. announced that its Board of Directors will conduct a comprehensive review of strategic alternatives focused on maximizing shareholder value.

June 28, 2022
·
4 min read
Drug Development

Oncolytics Biotech® Achieves Success Criteria for Efficacy in the Pancreatic Cancer Cohort of GOBLET

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that the pancreatic cancer cohort of the multi-indication phase 1/2 GOBLET study has met the efficacy expansion criteria for Stage 1 of the trial.

June 28, 2022
·
10 min read
BioCapital

LUNGevity Launches New Rare Mutations and Fusions Patient Gateway

The specialized resource offers patients with rare mutations or fusions in non-small cell lung cancer (NSCLC) and their caregivers access to treatment information, informative webinars, the latest scientific news, and a supportive community.

June 28, 2022
·
4 min read
Business

BioLineRx Announces Collaboration Agreement with GenFleet Therapeutics to Further Develop Motixafortide in Pancreatic Ductal Adenocarcinoma (PDAC)

GenFleet to design and execute randomized Phase 2b triple combination trial of Motixafortide in first-line metastatic PDAC patients in China.

June 28, 2022
·
9 min read